ArticlePloS one2023

Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy.

Jan-Niklas Becker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.